refraction was performed just before fundus evaluation. A pediatric lid speculum was placed gently between the eyelids and refraction measurement was performed with streak skiascopy (Welch Allyn Elite Retinoscope, Welch Allyn Inc., USA) (12) . Retinoscopy was performed at approximately 67 cm, neutralizing each principal meridian separately and then subtracting the empirically derived 1.5 D from the final spherical neutralizing lens. Spherical equivalent and cylindrical power measurements were recorded. Spherical equivalent was calculated as (spherical equivalent = sphere + [cylinder / 2]).
ROP examination
For the funduscopic examination with scleral indentation, after instillation of topical anesthetic 0.5% proparacaine hydrochloride, a binocular indirect ophthalmoscope (Heine Optotechnik, Germany) was used. ROP was graded according to the international classification of ROP (13) . The first examination was scheduled between 4 and 6 postnatal weeks. Follow-up examinations for ROP screening were planned at an interval of approximately 1 to 3 weeks according to the results of the retinal findings, until normal vascularization proceeded to zone 3.
Biometry measurement Biometry was measured with an ultrasound biometer (Compact Touch Ultrasound System, France
). An A-scan probe was placed gently and perpendicularly on the central cornea. Special attention was given to avoiding any indentation of cornea. For the right eyes, the average values of 5 measurements of anterior chamber depth, lens thickness, and vitreous and axial length were recorded.
Statistical analysis
Birth weight, gestational age, sex, zone and stage of acute ROP at the examination, refraction measurement, and biometry measurement were recorded. These values were compared between premature infants with or without ROP. Infants were grouped according to postmenstrual age at the time of ocular examination. Group 
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Results
A total of 894 infants (451 females and 443 males) were recruited for the study. Number, sex, mean postnatal age, gestational age, and birth weight of groups are shown in Tables 1 and 2 . The gestational age of infants ranged from 23 to 36 weeks (mean: 30.9 ± 2.8 weeks), the postmenstrual age of infants ranged from 28 to 51 weeks (mean: 39.6 ± 4.6 weeks), and the birth weight of infants ranged from 560 to 2670 g (mean: 1506 ± 484 g). Most infants were examined between 38 and 41 postmenstrual weeks (Group 3). The number of infants without ROP (527) was higher than the number of infants with ROP (367). In infants with ROP, 4 infants developed zone 1 stage 1, 134 infants zone 2 stage 1, 17 infants zone 2 stage 2, 10 infants zone 2 stage 3, 193 infants zone 3 stage 1, 7 infants zone 3 stage 2, and 2 infants zone 3 stage 3; as a result, 367 infants had developed ROP at the examination time. Table 3 shows the mean anterior chamber depth, lens thickness, vitreous length, axial length, spherical equivalent, and astigmatism of infants. Apart from Group 1, the mean anterior chamber depth of infants with ROP was lower than in infants without ROP. However, the differences were not statistically significant (P > 0.05). The mean lens thickness of infants did not differ significantly among groups (P > 0.05). In Group 2, the mean vitreous length and axial length of infants with ROP were significantly lower than in infants without ROP (P = 0.011, P = 0.001, respectively). In the other groups, the difference between mean vitreous length and axial length among infants was not significant (P > 0.05). In addition, the mean spherical equivalent and astigmatism did not differ significantly in any of the groups (P > 0.05). Anterior chamber depth, lens thickness, vitreous length, and axial length showed a linear growth throughout the follow-up period (Figure 1 
Discussion
Evidence showed that vitreous length and axial length differed between infants with or without ROP in Group 2 (34 to 37 postmenstrual weeks). In addition, infants with ROP in Group 2 showed shorter posterior segments. Neither the anterior chamber depth nor the lens thickness altered in infants with or without ROP in the study population. Maximum elongation was observed in vitreous length and, as a result, in axial length during the study period. The spherical equivalent developed correspondingly to the growth of postmenstrual age. However, the increase of astigmatism power was limited.
ROP is a disease affecting the growth of the eyeballs and the development of refraction. ROP may lead to impaired visual acuity and/or blindness in children. Therefore, it is important to determine the dimensions of the globe and measure the refractive errors for understanding this disease and its effects (14, 15) . It has been revealed that ROP is a risk factor for strabismus, visual impairments, and abnormal refractive errors including anisometropia, high myopia, hyperopia, or astigmatism. Changes in lens thickness or in the anterior segment depth are associated with high myopia and with a mechanism of altered anterior segment development in ROP (16, 17) . Eyes of premature infants with ROP have shallower anterior chambers, shorter axial length, and more highly curved corneas (7). Laws et al. studied a total of 496 readings from 171 infants between 32 and 41 weeks postconceptual age. They found that mean axial length increased by 1.38 mm for the left eye (15.27 to 16.65 mm) and by 1.35 mm for the right eye between 32 and 41 weeks postconceptual age. During this study period, the mean growth rate was 0.18 mm/week for both eyes (18) . These results are very close to the data in our study. In our analyzed examination, the growth rate of axial length was 0.64 mm per month; the axial length elongated from 15.52 to 18.09 mm between 28 and 51 weeks. Similarly, Cook et al. examined 136 premature babies longitudinally between 32 and 52 weeks postmenstrual age and showed that axial length grew linearly throughout the study period. They reported that as the stage of ROP increased, the average axial length and posterior segment length decreased. Moreover, they found that average anterior chamber depth and lens thickness did not vary significantly between stages of ROP (7) . Unlike the investigation of Cook et al., our study included only 12 infants with stage 3 and excluded infants with ROP at or above stage 4. We determined that vitreous length and axial length differed significantly only in Group 2 (34 to 37 postmenstrual weeks) among infants with or without ROP. Although not statistically significant in all groups, it is noteworthy that the axial length of infants with ROP is shorter.
We previously investigated the axial length of 374 eyes in 187 premature infants at 40 weeks of mean postmenstrual age and reported that there were no differences in axial length between infants with and without ROP (19) . In the present study we achieved similar results, except for infants between 34 and 37 weeks postmenstrual age. We worked with more infants and analyzed a broader range of postmenstrual ages between 28 and 51 weeks than in the former study.
It is clear that the vitreous chamber was the most prolonged part of the eye. It was elongated from 8.88 to 11.3 mm between 28 and 51 postmenstrual weeks. Hereby, the axial length increased by 0.64 mm per month and reached 18.09 mm at approximately 49 postmenstrual weeks (the mean postmenstrual week of Group 5) . When examining the vitreous length and axial length of infants with or without ROP, significant differences were seen only between 34 and 37 postmenstrual weeks. We suggest that the elongation of the globe is affected by ROP disease during this period. It may be related to the appearance of the ROP disease after the fourth postnatal week.
The refractive status of premature infants differs from that of full-term infants. The majority of changes in refractive errors appear in the first year of life. It has long been known that infants are usually hyperopic, and refractive powers decrease during infancy and early childhood. Studies of refractive development have shown that the mean refractive error is around +2 D in newborns (20) . There is higher prevalence and variance of myopia in preterm school children (21) . The exact mechanism of myopia related to ROP is unknown and may be due to thickening of the lens or alteration of the corneal curvature, elongation of the globe, or a combination of all these factors (22, 23) . Despite the existing data on the development of refraction in infancy and childhood, few studies have documented the changes in refractive error in the earliest measurable weeks of premature life (6, 7, 24) . Extremely preterm babies are recognized to be myopic, and term babies are recognized to be hypermetropic (24) . It was demonstrated that refractive error changed by 3 months of postmenstrual age, and stage 3 eyes had less hypermetropia than other stages, with the difference being greater in the treated eyes (7) . In the present study, there was no difference in the mean values of refractive error between infants with or without ROP. The spherical equivalent increased linearly during the follow-up period.
One of the limitations of this study was the use of cycloplegic agents other than cyclopentolate or atropine for cycloplegia. Cycloplegia is essential for measuring the refractive error and eliminating any uncontrolled accommodation in children (25) . To avoid the side effects of cyclopentolate, we preferred to use topical tropicamide for cycloplegia. Tropicamide is a parasympatholytic drug. The onset of action of the drug begins 15 to 30 min after instillation. Its duration of action is 4 to 6 h, having the shortest half-life of all drugs. Because it is eliminated quickly from the body, it is ideal for children with special needs and other instances of hypersensitivity to cholinergic agents. Tropicamide has fewer side effects than other cycloplegics (26) (27) (28) . In addition, it does not require long-term follow-up of the same patients. It is required to evaluate infants from the preterm period until 1 year of age. Further studies about the measurement of biometric components in the developing eye may help clarify the factors underlying the development of abnormal refractive errors in infants with ROP.
In conclusion, prospectively examining the ocular growth parameters, refractive statuses, and their relation with ROP in premature infants during the early months of infancy provides important information to clinicians for understanding the growth of biometric variables and the development of refractive errors. Anterior chamber depth, lens thickness, vitreous length, and axial length showed linear growth throughout the follow-up period. Between 34 and 37 postmenstrual weeks, the vitreous length and axial length of infants with ROP were lower than in infants without ROP. The maximum elongation was observed in vitreous length and, as a result, in axial length. The spherical equivalent increased linearly during the follow-up period. However, the increase of astigmatism power was slight. Moreover, the refractive errors in premature infants with ROP did not differ from those of infants without ROP.
